Doctor of Podiatric Medicine Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Robert Klein

Podiatrist, Foot & Ankle Surgery Greenville, SC Doctor of Podiatric Medicine

NPI 1376543686 CMS profile 197814

200 Patewood Dr Ste C300, Greenville, SC 29615

Open in the dashboard

General payments

$358,195

396 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$21,489 paid to institutions, not to them · program years 2022–2024

Through program year 2025, Robert Klein of Greenville, SC is reported in the CMS Open Payments database as having received $358,195 across 396 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $21,489 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 99th percentile of Podiatrist, Foot & Ankle Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $49,601 39
2024 General $108,926 86
2023 General $64,615 67
2022 General $54,659 61
2021 General $30,814 61
2020 General $13,209 27
2019 General $36,371 55

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Robert Klein
  • Podiatrist, Foot & Ankle Surgery median
  • Middle half of Podiatrist, Foot & Ankle Surgery
  • National median

In program year 2025, general payments to Robert Klein were reported at $49,601. Among 6,994 Podiatrist, Foot & Ankle Surgery profiles paid that year, the median was $424 and the middle half received between $139 and $1,306.

Show as a table
Year Robert Klein Podiatrist, Foot & Ankle Surgery median Middle half National median
2019 $36,371 $389 $118–$1,406 $163
2020 $13,209 $191 $62–$691 $114
2021 $30,814 $329 $104–$1,341 $132
2022 $54,659 $419 $125–$1,611 $149
2023 $64,615 $377 $128–$1,164 $160
2024 $108,926 $394 $134–$1,168 $164
2025 $49,601 $424 $139–$1,306 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. KCI USA, Inc $187,830 195 payments
  2. Solventum Corporation $150,847 99 payments
  3. Integra LifeSciences Corporation $8,666 32 payments
  4. Kerecis Limited $2,448 6 payments
  5. Hartmann USA, Inc. $1,948 5 payments
  6. Darco International, Inc. $1,325 1 payment
  7. LifeNet Health $964 6 payments
  8. BSN Medical Inc $818 4 payments
  9. Musculoskeletal Transplant Foundation Inc. $703 3 payments
  10. Urgo Medical North America, LLC $582 3 payments
  11. Other $2,064 42 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $200,475 71 payments
  2. Consulting Fee $95,121 96 payments
  3. Travel and Lodging $39,730 100 payments
  4. Education $14,095 5 payments
  5. Food and Beverage $8,737 123 payments
  6. Gift $36 1 payment
Products named General payments · program years 2019–2025
  1. ACTIV.A.C. $155,461 104 payments
  2. PROMOGRAN PRISMA $128,990 97 payments
  3. V.A.C. DERMATAC $86,918 60 payments
  4. V.A.C. VERAFLO $81,894 67 payments
  5. 3M Coban $46,787 25 payments
  6. SNAP $46,586 35 payments
  7. 3M Cavilon $42,131 24 payments
  8. PROMOGRAN $37,509 15 payments
  9. V.A.C. VERAFLO CLEANSE CHOICE $32,856 21 payments
  10. PREVENA $32,164 37 payments
  11. Other $264,773 370 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 5 drugs

Part D claims

253

Median for Podiatry: 160

Drug cost

$2,350

Median for Podiatry: $2,368

Branded share of claims

24.9%

Median for Podiatry: 12.7%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Doxycycline Hyclate Generic 119 $1,066
Cefadroxil Generic 46 $636
Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav Brand 63 $505
Ciprofloxacin Hcl Generic 13 $98
Mupirocin Generic 12 $46

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 14,093 Part D prescribers listed as Podiatry; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 25 billing codes

Paid by Medicare

$37,712

Medicare's payments for the services billed

Medicare patients

113

Average age 73

Services billed

652

40 women, 73 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Diabetes 75%
High blood pressure 75%
Chronic kidney disease 64%
Arthritis 54%
Ischemic heart disease 53%
Heart failure 46%
Depression 39%
Atrial fibrillation 34%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

396 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record